These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 19287123

  • 21. Phase II clinical trial of capecitabine in the treatment of advanced, persistent or recurrent squamous cell carcinoma of the cervix with translational research: a gynecologic oncology group study.
    Garcia AA, Blessing JA, Darcy KM, Lenz HJ, Zhang W, Hannigan E, Moore DH.
    Gynecol Oncol; 2007 Mar; 104(3):572-9. PubMed ID: 17049588
    [Abstract] [Full Text] [Related]

  • 22. Detailed analysis of five mutations in dihydropyrimidine dehydrogenase detected in cancer patients with 5-fluorouracil-related side effects.
    Gross E, Ullrich T, Seck K, Mueller V, de Wit M, von Schilling C, Meindl A, Schmitt M, Kiechle M.
    Hum Mutat; 2003 Dec; 22(6):498. PubMed ID: 14635116
    [Abstract] [Full Text] [Related]

  • 23. Relationship between single nucleotide polymorphisms and haplotypes in DPYD and toxicity and efficacy of capecitabine in advanced colorectal cancer.
    Deenen MJ, Tol J, Burylo AM, Doodeman VD, de Boer A, Vincent A, Guchelaar HJ, Smits PH, Beijnen JH, Punt CJ, Schellens JH, Cats A.
    Clin Cancer Res; 2011 May 15; 17(10):3455-68. PubMed ID: 21498394
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Bolus 5-fluorouracil as an alternative in patients with cardiotoxicity associated with infusion 5-fluorouracil and capecitabine: a case series.
    Saif MW, Garcon MC, Rodriguez G, Rodriguez T.
    In Vivo; 2013 May 15; 27(4):531-4. PubMed ID: 23812226
    [Abstract] [Full Text] [Related]

  • 29. Polymorphisms in the thymidylate synthase and dihydropyrimidine dehydrogenase genes predict response and toxicity to capecitabine-raltitrexed in colorectal cancer.
    Salgado J, Zabalegui N, Gil C, Monreal I, Rodríguez J, García-Foncillas J.
    Oncol Rep; 2007 Feb 15; 17(2):325-8. PubMed ID: 17203168
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)- related toxicity compared with controls.
    Raida M, Schwabe W, Häusler P, Van Kuilenburg AB, Van Gennip AH, Behnke D, Höffken K.
    Clin Cancer Res; 2001 Sep 15; 7(9):2832-9. PubMed ID: 11555601
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil.
    van Kuilenburg AB.
    Eur J Cancer; 2004 May 15; 40(7):939-50. PubMed ID: 15093568
    [Abstract] [Full Text] [Related]

  • 34. Dihydropyrimidine dehydrogenase 85T>C mutation is associated with ocular toxicity of 5-fluorouracil: a case report.
    Baskin Y, Amirfallah A, Unal OU, Calibasi G, Oztop I.
    Am J Ther; 2015 May 15; 22(2):e36-9. PubMed ID: 24434920
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Prevention of severe toxicity from capecitabine, 5-fluorouracil and tegafur by screening for DPD-deficiency].
    Deenen MJ, Cats A, Mandigers CM, Soesan M, Terpstra WE, Beijnen JH, Schellens JH.
    Ned Tijdschr Geneeskd; 2012 May 15; 156(48):A4934. PubMed ID: 23191966
    [Abstract] [Full Text] [Related]

  • 37. Hand-foot syndrome variant in a dihydropyrimidine dehydrogenase-deficient patient treated with capecitabine.
    Saif MW, Elfiky A, Diasio R.
    Clin Colorectal Cancer; 2006 Sep 15; 6(3):219-23. PubMed ID: 17026792
    [Abstract] [Full Text] [Related]

  • 38. Two cases of 5-fluorouracil toxicity linked with gene variants in the DPYD gene.
    Ofverholm A, Arkblad E, Skrtic S, Albertsson P, Shubbar E, Enerbäck C.
    Clin Biochem; 2010 Feb 15; 43(3):331-4. PubMed ID: 19822137
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Unilateral hand-foot syndrome: an extraordinary side effect of capecitabine.
    Disel U, Gürkut O, Abali H, Kaleağasi H, Mertsoylu H, Ozyilkan O, Saif MW.
    Cutan Ocul Toxicol; 2010 Jun 15; 29(2):140-2. PubMed ID: 20298142
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.